Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Specific Nuclear Magnetic Resonance Lipoprotein Subclass Profiles and Central Arterial Stiffness in Type 1 Diabetes Mellitus: A Case Control Study.

Llauradó G, Amigó N, Cano A, Ballesta S, Albert L, Mazarico I, Fernández-Veledo S, Pedro-Botet J, Vendrell J, González-Clemente JM.

J Clin Med. 2019 Nov 5;8(11). pii: E1875. doi: 10.3390/jcm8111875.

2.

Lipid Profile Rather Than the LCAT Mutation Explains Renal Disease in Familial LCAT Deficiency.

Lamiquiz-Moneo I, Civeira F, Gómez-Coronado D, Blanco-Vaca F, Villafuerte-Ledesma HM, Gil M, Amigó N, Mateo-Gallego R, Cenarro A.

J Clin Med. 2019 Nov 3;8(11). pii: E1860. doi: 10.3390/jcm8111860.

3.

Gelsolin: a new biomarker of disease activity in SLE patients associated with HDL-c.

Parra S, Heras M, Herrero P, Amigó N, Garcés E, Girona J, Correig X, Canela N, Castro A.

Rheumatology (Oxford). 2019 Aug 23. pii: kez293. doi: 10.1093/rheumatology/kez293. [Epub ahead of print]

PMID:
31504936
4.

Serum Paraoxonase-1-Related Variables and Lipoprotein Profile in Patients with Lung or Head and Neck Cancer: Effect of Radiotherapy.

Rodríguez-Tomàs E, Murcia M, Arenas M, Arguís M, Gil M, Amigó N, Correig X, Torres L, Sabater S, Baiges-Gayà G, Cabré N, Luciano-Mateo F, Hernández-Aguilera A, Fort-Gallifa I, Camps J, Joven J.

Antioxidants (Basel). 2019 Jul 10;8(7). pii: E213. doi: 10.3390/antiox8070213.

5.

HDL Triglycerides: A New Marker of Metabolic and Cardiovascular Risk.

Girona J, Amigó N, Ibarretxe D, Plana N, Rodríguez-Borjabad C, Heras M, Ferré R, Gil M, Correig X, Masana L.

Int J Mol Sci. 2019 Jun 27;20(13). pii: E3151. doi: 10.3390/ijms20133151.

6.

An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients.

Bermudez-Lopez M, Forne C, Amigo N, Bozic M, Arroyo D, Bretones T, Alonso N, Cambray S, Del Pino MD, Mauricio D, Gorriz JL, Fernandez E, Valdivielso JM.

Expert Opin Ther Targets. 2019 Jul;23(7):619-630. doi: 10.1080/14728222.2019.1620206. Epub 2019 May 23.

PMID:
31100024
7.

Biological Response to Meal Ingestion: Gender Differences.

Monrroy H, Borghi G, Pribic T, Galan C, Nieto A, Amigo N, Accarino A, Correig X, Azpiroz F.

Nutrients. 2019 Mar 26;11(3). pii: E702. doi: 10.3390/nu11030702.

8.

Meal Enjoyment and Tolerance in Women and Men.

Monrroy H, Pribic T, Galan C, Nieto A, Amigo N, Accarino A, Correig X, Azpiroz F.

Nutrients. 2019 Jan 8;11(1). pii: E119. doi: 10.3390/nu11010119.

9.

Metabolic profiling and targeted lipidomics reveals a disturbed lipid profile in mothers and fetuses with intrauterine growth restriction.

Miranda J, Simões RV, Paules C, Cañueto D, Pardo-Cea MA, García-Martín ML, Crovetto F, Fuertes-Martin R, Domenech M, Gómez-Roig MD, Eixarch E, Estruch R, Hansson SR, Amigó N, Cañellas N, Crispi F, Gratacós E.

Sci Rep. 2018 Sep 11;8(1):13614. doi: 10.1038/s41598-018-31832-5.

10.

Metabolomic signature of the postprandial experience.

Malagelada C, Pribic T, Ciccantelli B, Cañellas N, Gomez J, Amigo N, Accarino A, Correig X, Azpiroz F.

Neurogastroenterol Motil. 2018 Dec;30(12):e13447. doi: 10.1111/nmo.13447. Epub 2018 Aug 13.

PMID:
30101554
11.

Patients With Systemic Lupus Erythematosus Show an Increased Arterial Stiffness That is Predicted by IgM Anti-β2 -Glycoprotein I and Small Dense High-Density Lipoprotein Particles.

Parra S, Lopez-Dupla M, Ibarretxe D, de Las Heras M, Amigó N, Català A, Benavent M, Garcés E, Navarro A, Castro A.

Arthritis Care Res (Hoboken). 2019 Jan;71(1):116-125. doi: 10.1002/acr.23594.

12.

Lipoprotein profile assessed by 2D-1H-NMR and subclinical atherosclerosis in children with familial hypercholesterolaemia.

Rodríguez-Borjabad C, Ibarretxe D, Girona J, Ferré R, Feliu A, Amigó N, Guijarro E, Masana L, Plana N; DECOPIN Group.

Atherosclerosis. 2018 Mar;270:117-122. doi: 10.1016/j.atherosclerosis.2018.01.040. Epub 2018 Jan 31.

PMID:
29407879
13.

LipSpin: A New Bioinformatics Tool for Quantitative 1H NMR Lipid Profiling.

Barrilero R, Gil M, Amigó N, Dias CB, Wood LG, Garg ML, Ribalta J, Heras M, Vinaixa M, Correig X.

Anal Chem. 2018 Feb 6;90(3):2031-2040. doi: 10.1021/acs.analchem.7b04148. Epub 2018 Jan 17.

PMID:
29293319
14.

Plasma inducible degrader of the LDLR, soluble low-density lipoprotein receptor, and proprotein convertase subtilisin/kexin type 9 levels as potential biomarkers of familial hypercholesterolemia in children.

Girona J, Rodríguez-Borjabad C, Ibarretxe D, Heras M, Amigo N, Feliu A, Masana L, Plana N; DECOPIN Group.

J Clin Lipidol. 2018 Jan - Feb;12(1):211-218. doi: 10.1016/j.jacl.2017.10.003. Epub 2017 Oct 12.

PMID:
29102496
15.

Relationship between noninvasive scores of nonalcoholic fatty liver disease and nuclear magnetic resonance lipoprotein abnormalities: A focus on atherogenic dyslipidemia.

Amor AJ, Pinyol M, Solà E, Catalan M, Cofán M, Herreras Z, Amigó N, Gilabert R, Sala-Vila A, Ros E, Ortega E.

J Clin Lipidol. 2017 Mar - Apr;11(2):551-561.e7. doi: 10.1016/j.jacl.2017.02.001. Epub 2017 Feb 22.

PMID:
28502513
16.

Unravelling and Quantifying the "NMR-Invisible" Metabolites Interacting with Human Serum Albumin by Binding Competition and T2 Relaxation-Based Decomposition Analysis.

Barrilero R, Ramírez N, Vallvé JC, Taverner D, Fuertes R, Amigó N, Correig X.

J Proteome Res. 2017 May 5;16(5):1847-1856. doi: 10.1021/acs.jproteome.6b00814. Epub 2017 Apr 4.

PMID:
28345344
17.

Improvement of the omega 3 index of healthy subjects does not alter the effects of dietary saturated fats or n-6PUFA on LDL profiles.

Dias CB, Amigó N, Wood LG, Mallol R, Correig X, Garg ML.

Metabolism. 2017 Mar;68:11-19. doi: 10.1016/j.metabol.2016.11.014. Epub 2016 Dec 1.

PMID:
28183443
18.

Circulating PCSK9 levels and CETP plasma activity are independently associated in patients with metabolic diseases.

Girona J, Ibarretxe D, Plana N, Guaita-Esteruelas S, Amigo N, Heras M, Masana L.

Cardiovasc Diabetol. 2016 Aug 4;15(1):107. doi: 10.1186/s12933-016-0428-z.

19.

Impact of epidermal fatty acid binding protein on 2D-NMR-assessed atherogenic dyslipidemia and related disorders.

Ibarretxe D, Girona J, Amigó N, Plana N, Ferré R, Guaita S, Mallol R, Heras M, Masana L.

J Clin Lipidol. 2016 Mar-Apr;10(2):330-8.e2. doi: 10.1016/j.jacl.2015.12.012. Epub 2015 Dec 22.

PMID:
27055964
20.

Lipoprotein hydrophobic core lipids are partially extruded to surface in smaller HDL: "Herniated" HDL, a common feature in diabetes.

Amigó N, Mallol R, Heras M, Martínez-Hervás S, Blanco Vaca F, Escolà-Gil JC, Plana N, Yanes Ó, Masana L, Correig X.

Sci Rep. 2016 Jan 18;6:19249. doi: 10.1038/srep19249.

Supplemental Content

Loading ...
Support Center